WO2001060330A1 - Tanning preparation for the skin - Google Patents

Tanning preparation for the skin Download PDF

Info

Publication number
WO2001060330A1
WO2001060330A1 PCT/NL2001/000122 NL0100122W WO0160330A1 WO 2001060330 A1 WO2001060330 A1 WO 2001060330A1 NL 0100122 W NL0100122 W NL 0100122W WO 0160330 A1 WO0160330 A1 WO 0160330A1
Authority
WO
WIPO (PCT)
Prior art keywords
tanning
preparation according
tanning preparation
emulsion
skin
Prior art date
Application number
PCT/NL2001/000122
Other languages
French (fr)
Inventor
Leo Anton Jager
Lukas Jan Jager
Edward Philip Jager
Hans Marcel Brand
Original Assignee
Dija Zeist B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dija Zeist B.V. filed Critical Dija Zeist B.V.
Priority to DK01910238T priority Critical patent/DK1255531T3/en
Priority to AT01910238T priority patent/ATE268589T1/en
Priority to EP01910238A priority patent/EP1255531B1/en
Priority to AU2001237816A priority patent/AU2001237816A1/en
Priority to CA002400203A priority patent/CA2400203A1/en
Priority to DE60103735T priority patent/DE60103735T2/en
Publication of WO2001060330A1 publication Critical patent/WO2001060330A1/en
Priority to US10/218,037 priority patent/US6649149B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0295Liquid crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/604Alkylpolyglycosides; Derivatives thereof, e.g. esters

Definitions

  • the invention relates to a tanning preparation for the skin comprising at least one tyrosine derivative of formula 1
  • this known preparation comprises an adenosine compound such as an ester or a salt of adenosine mono-, di- or triphosphoric acid.
  • Adenosine di- and triphosphate are known to be involved in various enzymatic reactions in the body, in particular in processes requiring energy such as the oxidation of sugars, proteins and fats .
  • the activator used is not a substance which naturally occurs in the body and has an enzymatic reaction, but instead a compound which preferably has humectant activity.
  • the invention therefore relates, in a firs embodiment, to a tanning preparation of the type mentioned at the outset, which is characterized in that the activator consists of an aliphatic polyol having at least 10 C atoms in the molecule.
  • the aliphatic polyol consists of a hexadecanetriol, in particular phytantriol.
  • Phytantriol or 3 , 7, 11, 15-tetramethyl-l , 2 , 3-hexadecane- triol, is a compound which improves the moisture retention capability of the skin and of hair and is therefore used in shampoos and hair conditioners; in this context, the Japanese patent application Kokai No JP-A2-61, 236 , 737 can be mentioned.
  • an aliphatic polyol, and in particular phytantriol improves the deposition of a tyrosine derivative as specified hereinabove on and in the skin, thereby allowing rapid and persistent, natural tanning of the skin to be achieved.
  • Such an effect is rather surprising, all the more since only very small amounts of aliphatic polyol, in particular phytantriol, need be present in the tanning preparation.
  • the tanning preparation according to the invention merely contains at least 0.01 wt% of phytantriol, it being noted in this context that even with this very small amount of phytantriol, rapid tanning of the skin is achieved.
  • Tyrosine derivatives which are particularly suitable for use in a tanning preparation according to the invention are N-acetyltyrosine; N-acetyl yrosine ethyl ester; N-my- ristoyltyrosine; N-myristoyltyrosine-myristylester; N-palmi- toyltyrosine; N-palmitoyltyrosine-palmityl ester; N-stearo- yltyrosine and N-stearoyltyrosine stearyl ester.
  • the preparation further comprises riboflavin.
  • Riboflavin or vitamin B2 is 7 , 8-dimethyl-10 (D-l ' - ribityl) -isoalloxazine and is a compound which in the body is converted into two coenzymes, viz. FMN and FAD, which are involved in numerous oxidation-reduction processes.
  • riboflavin as an activator in a sunburn preparation comprising a tyrosine derivative is known per se from CH 642 537.
  • the use of riboflavin according to the invention is optional, moreover, rather than mandatory as in CH 642 537.
  • this preparation further comprises a UV filter.
  • the UV filter used can be any of the compounds suitable for this purpose in the customary quantities without any limitation.
  • the tanning preparation according to the invention can further be in the form of a gel, lotion, cream, foam, spray based on water and/or an aqueous alcohol and/or an aqueous glycol, or of an emulsion of the type O/W, /O, 0/ /O, etc.
  • Used as a solvent for aqueous solutions is, for example, water, aqueous ethanol, aqueous isopropanol, aqueous glycols or a mixture thereof.
  • a suitable emulsifier it is possible to form an emulsion or a gel, while an aerosol or a foam can be formed with the aid of a suitable propellant.
  • tyrosine derivatives carrying relatively long-chain substituents are preferably dissolved in an oil.
  • mineral oils such as paraffin oil, vegetable oil such as olive oil and animal oil such as squalene.
  • Waxes such as beeswax and fat-dissolving glycols and polyglycols can also be used, however.
  • a tanning preparation according to the invention can comprise customary adjuvants, depending on the desired form of the preparation, such as surfactants, swelling agents or thickeners, emulsifiers and hydrolysed vegetable protein such as hydrolysed soya protein and hydrolysed wheat protein.
  • the invention further relates to a method of preparing a tanning preparation as described hereinabove, which is characterized in that a mixture is formed which comprises 5 - 15 wt% of N-acetyl-L-tyrosine, 0.5 - 5 wt% of phytantriol, 15 - 25 wt% of butylene glycol,
  • a mixture is formed which comprises 10 wt% of N-acetyl-L-tyrosine, 20 wt% of butylene glycol,
  • the present invention relates to a controlled release tanning preparation.
  • a controlled release tanning preparation With respect to the phenomenon of controlled release preparations the following explanation is given.
  • Stable emulsions produced for application in food, pharmacy, personal care and cosmetics, lacquers and coatings, paper products, etc., are characterized by the presence of a nematic, liquid crystalline structure.
  • thermodynamically stable liquid crystalline (LC) structures is dependant on the temperature, and it is a boundary condition for stable emulsions that these LC structures are manifest in the temperature range of storage and application of the particular product.
  • the nematic liquid crystalline structures reside in the continuous phase of emulsions. These are organised in double layers whereby the theme "like-dissolves-like" is applicable.
  • the double layers, relative to the continuous phase applicable, may be organised as:
  • « H » represents the hydrophilic (water-loving) part of the surface active agent
  • « L » represents the lipophilic (oil-loving) part of the surface active agent.
  • structure (1) will reside in the water phase and is characteristic for Oil-in-Water (O/W) emulsions.
  • Structure (2) will reside in the oil phase and is therefore characteristic for Water-in-Oil (W/O) emulsions .
  • the LC structure is present in the form of a sponge structure. A number of parameters are determining the characteristics of the frequently called “the fourth phase” . These are:
  • the mechanical strength of the LC is an important parameter for the cosmetic application of active ingredients relative to the bio-availability of these active ingredients.
  • the LC structures are quickly deteriorated because of the influence of shear applied during rubbing in, the influence of electrolytes, the activity of enzymes present on the skin and because of the presence of liquid crystalline structures relative to the naturally occurring sebum (the sebum also exhibits liquid crystalline properties, and easily dissolves the LC structures present in cosmetic emulsions) .
  • Active principles could be considered to be moisturisers/humectants, oil/water-soluble UV-filters, flavonoids, saponines, alkaloids, terpenoids, vitamins, 2- hydroxy carboxylic acids (AHA's), insect repellents, amino acid biovectors, (poly) -saccharides, etc.
  • hydrocolloids such as naturals gums (such as xanthan gum, karaya gum, guar gum, gum ghatti, gum Arabic, etc.), cellulose derivatives (such as methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, etc.), synthetic hydrophilic products such as homo-and co-polymers of acrylic acid, methacrylic acid, crotonic acid, etc, natural clays such as hectorites, bentonites, montmorrilonites, and others.
  • naturals gums such as xanthan gum, karaya gum, guar gum, gum ghatti, gum Arabic, etc.
  • cellulose derivatives such as methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, etc.
  • synthetic hydrophilic products such as homo-and co-polymers of acrylic acid, methacrylic acid, crotonic acid, etc, natural clay
  • the mechanical strength of the LC structures can easily be measured in terms of rheological parameters such as yield stress value, visco-elastic behaviour and flow patterns.
  • the same mechanism can be used for a controlled release mechanism of active substances.
  • cholesterol can be pulled out of the double layer and make the contents of the liquid crystalline cavity available to the skin. This mechanism may coincide with enzymatic degradation of the liquid crystalline sponge structure. The naturally occuring receptors for cholesterol are thus used to enable controlled release.
  • the mechanical strength can be increased by using the before mentioned hydrocolloids.
  • Cholesterol is soluble in the liquid crystalline phase made of a variety of amphiphilic molecules and therefore an artificial membrane is formed that has similar properties as the naturally occurring subcutaneous membranes, and that is treated accordingly.
  • the emollients can be chosen from the emollients, which are used in personal care and cosmetic preparations, in a concentration in the range 0-45 %, preferably in the range 5- 20%.
  • Examples of applicable emollients are triglycerides of long chain, predominantly unsaturated fatty acids such as vegetable oils and artificially made triglycerides of long chain unsaturated fatty acids, triglycerides of saturated medium chain fatty acids, liquid and semi-solid esters of mono- & polyhydric alcohols and carboxylic acids with 1-24 carbon atoms, liquid and semi-solid fatty alcohols & branched alcohols, their ethoxylates and propoxylates , liquid and semi-solid mineral and natural hydrocarbons, products having a steroid skeleton with an hydroxy functionality, their esters, ethoxylates and propoxylates, water-soluble products made by ethoxylation and/or propoxylation of suitable mono- and/or polyhydric alcohols and products usually identified as silicones such as cyclic and linear polydimethylsiloxanes and polyphenyltrimethylsiloxanes and derivates thereof made by ethoxylation and/or propoxylation.
  • An O/W lotion was prepared by mixing an oil phase and a water phase in a manner customary per se .
  • the oil phase used consisted of: 0.50 kg of phenoxyethanol (Phenonip, trade name, product of Nipa Industries, UK) , 10.00 kg of an ester mixture, consisting of cetyl palmitate, octyl stearate and glyceryl stearate (Cetiol 868, product from Cognis) , 6.00 kg of emulsifier mixture of ceteareth-20 and ceteareth-12 (Emulgade SE, product from Cognis) , 2.00 kg of cetearyl alcohol (Lanette 0, product from Cognis) .
  • the water phase consisted of 76.50 kg of water and 5.00 kg of tanning mixture according to the invention, consisting of:
  • a gel-type preparation was prepared by mixing a premix consisting of:
  • An 0/W lotion was formed in the same manner as in Example 1, and using the same substances and quantities, except that in the tanning mixture according to the invention the phytantriol used was replaced by adenosine triphosphate .
  • a preparation of this type is disclosed by DE 37 32 154.
  • the preparations specified in the abovementioned examples were subjected to tests on human skin, using a tanning bed comprising 22 80-Watt lamps and a face tanner comprising 5 15-Watt lamps.
  • the measuring equipment consisted of a melanin & erythema meter (Mexameter MX16 from Courage &_ Khazaka) .
  • the duration of an insolation was 20 minutes.
  • Emulsions were made, composed as described in table 3.
  • DMDM hydantoin 1, 3-bis- (hydroxymethyl) -5 , 5-dimethylimidazolidine- 2,4-dione.
  • Isopropylisostearate is a spreading agent, which improves the spreadability of the preparation on the skin.
  • Rheological additives are additives, which influence the mechanical strenght of the liquid crystalline structure of the emulsion to be prepared.
  • the mixture is homogenised ⁇ 1500 rpm during 2 minutes, without stirring during the addition.
  • the emulsion is stirred slowly with a planetary mixer while cooling gently.
  • emulsion 1 The results of emulsion 1 were compared to a similar emulsion in absence of Cholesterol, Xanthan Gum and Acrylates/Cio-3o Alkyl Acrylates Crosspolymer, whereby the formed emulsion is stable but where the mechanical strength is greatly reduced: emulsion 2.
  • Emulsion 2 has a much too high bio-availability of the moisturiser, while the system (emulsion 1) with build-in controlled release has a highly desirable bio-availability profile.
  • Example 5
  • Tanning acceleration using a controlled release tanning preparation according to the invention Tanning acceleration using a controlled release tanning preparation according to the invention.
  • butyl methoxydibenzoylmethane is a strong sequestering agent for transition metal ions the use of an additional sequestering agent such as trisodium ETDA is essential to avoid coloration of the final emulsion.
  • other UV filters can be used such as described in table 5 : the use of octocrylene instead of butyl methoxydibenzoylmethane & homosalate .
  • the MEXAMETER readings were respectively 92% and 94 %.
  • the bio-availability for the emulsion systems 5 A /5 B is such that less functional material can be used for the production of melanin.
  • the lower MEXAMETER readings for emulsions 5 A /5 B is attributed to the absence of a controlled release system using cholesterol.
  • the reduced bio-availability of the active ingredients (Acetyl Tyrosine/Pythantriol) probably originates from a high trans-epidermal flux of the active ingredients disabling full utilisation thereof.
  • the activity of the system Acetyl Tyrosine / Phytantriol can thus be further improved using controlled release systems based on amphiphilic products that form a liquid crystalline (LC) phase in the emulsion.
  • the mechanical strength of the LC phase can be monitored using a suitable rheological additive.
  • Controlled release of active principles such as moisturisers or tanning accelerators can be monitored by incorporating cholesterol in the LC phase.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Amplifiers (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Oscillators With Electromechanical Resonators (AREA)

Abstract

The invention relates to a tanning preparation for the skin comprising at least one tyrosine derivative of formula 1, where R1 = -H, -(CH¿2?)x-CH3, x being an integer from 1 to 20, R?2 = CH¿3CO-, CH3-(CH2)yCO-, y being an integer from 1 to 20, and an activator consisting of an aliphatic polyol having at least 10 C atoms in the molecule. The aliphatic polyol preferably consists of a hexadecanetriol, in particular phytantriol. Expediently, the tanning preparation is a gel, lotion, cream, foam, spray or emulsion. The invention further relates to a controlled release tanning preparation for the skin.

Description

Short title: Tanning preparation for the skin
The invention relates to a tanning preparation for the skin comprising at least one tyrosine derivative of formula 1
COOR,
| H C — NHR3
Figure imgf000002_0001
where
R1 = -H, -(CH2)X-CH3, x being an integer from 1 to 20, R2 = CH3CO-, CH3- (CH2)yCO-, y being an integer from 1 to 20, and an activator.
A preparation of this type is disclosed by
DE-C-3 732 154. As this publication states, the skin pigment melanin is formed in the skin from the amino acid tyrosine. This reaction takes place under the influence of light, heat and oxygen, with the aid of the enzyme tyrosinase.
On the basis of this known biological process it was found that certain tyrosine derivatives, in combination with an activator as a substitute for the expensive and chemically unstable enzyme, may lead to the desired tanning of the skin, if used as a sunburn preparation. As an activator, this known preparation comprises an adenosine compound such as an ester or a salt of adenosine mono-, di- or triphosphoric acid.
Adenosine di- and triphosphate are known to be involved in various enzymatic reactions in the body, in particular in processes requiring energy such as the oxidation of sugars, proteins and fats .
Surprisingly, a tanning preparation has now been found for the skin where the activator used is not a substance which naturally occurs in the body and has an enzymatic reaction, but instead a compound which preferably has humectant activity.
The invention therefore relates, in a firs embodiment, to a tanning preparation of the type mentioned at the outset, which is characterized in that the activator consists of an aliphatic polyol having at least 10 C atoms in the molecule.
Preferably, the aliphatic polyol consists of a hexadecanetriol, in particular phytantriol.
Phytantriol, or 3 , 7, 11, 15-tetramethyl-l , 2 , 3-hexadecane- triol, is a compound which improves the moisture retention capability of the skin and of hair and is therefore used in shampoos and hair conditioners; in this context, the Japanese patent application Kokai No JP-A2-61, 236 , 737 can be mentioned.
It has now been found that an aliphatic polyol, and in particular phytantriol, improves the deposition of a tyrosine derivative as specified hereinabove on and in the skin, thereby allowing rapid and persistent, natural tanning of the skin to be achieved. Such an effect is rather surprising, all the more since only very small amounts of aliphatic polyol, in particular phytantriol, need be present in the tanning preparation.
Preferably, the tanning preparation according to the invention merely contains at least 0.01 wt% of phytantriol, it being noted in this context that even with this very small amount of phytantriol, rapid tanning of the skin is achieved. Tyrosine derivatives which are particularly suitable for use in a tanning preparation according to the invention are N-acetyltyrosine; N-acetyl yrosine ethyl ester; N-my- ristoyltyrosine; N-myristoyltyrosine-myristylester; N-palmi- toyltyrosine; N-palmitoyltyrosine-palmityl ester; N-stearo- yltyrosine and N-stearoyltyrosine stearyl ester.
According to another expedient embodiment of a preparation according to the invention, the preparation further comprises riboflavin.
Riboflavin or vitamin B2 is 7 , 8-dimethyl-10 (D-l ' - ribityl) -isoalloxazine and is a compound which in the body is converted into two coenzymes, viz. FMN and FAD, which are involved in numerous oxidation-reduction processes.
It should be noted that the use of riboflavin as an activator in a sunburn preparation comprising a tyrosine derivative is known per se from CH 642 537. An activator consisting of an aliphatic polyol, as described hereinabove, is not mentioned in this publication, however. The use of riboflavin according to the invention is optional, moreover, rather than mandatory as in CH 642 537.
According to yet another expedient embodiment of a preparation according to the invention, this preparation further comprises a UV filter. The UV filter used can be any of the compounds suitable for this purpose in the customary quantities without any limitation.
The tanning preparation according to the invention can further be in the form of a gel, lotion, cream, foam, spray based on water and/or an aqueous alcohol and/or an aqueous glycol, or of an emulsion of the type O/W, /O, 0/ /O, etc. Used as a solvent for aqueous solutions is, for example, water, aqueous ethanol, aqueous isopropanol, aqueous glycols or a mixture thereof. By adding a suitable emulsifier it is possible to form an emulsion or a gel, while an aerosol or a foam can be formed with the aid of a suitable propellant. It should be noted that the tyrosine derivatives carrying relatively long-chain substituents are preferably dissolved in an oil. Examples of these are mineral oils such as paraffin oil, vegetable oil such as olive oil and animal oil such as squalene. Waxes such as beeswax and fat-dissolving glycols and polyglycols can also be used, however.
In addition, a tanning preparation according to the invention can comprise customary adjuvants, depending on the desired form of the preparation, such as surfactants, swelling agents or thickeners, emulsifiers and hydrolysed vegetable protein such as hydrolysed soya protein and hydrolysed wheat protein.
The invention further relates to a method of preparing a tanning preparation as described hereinabove, which is characterized in that a mixture is formed which comprises 5 - 15 wt% of N-acetyl-L-tyrosine, 0.5 - 5 wt% of phytantriol, 15 - 25 wt% of butylene glycol,
1 - 5 wt% of hydrolysed vegetable protein, 0.1 - 5 wt% of polysorbate-20, 0 - 5 wt% of riboflavin, remainder: water/alcohol, and this mixture is taken up in an amount of from 1 to 10%, preferably 5%, in a pharmacologically acceptable base to form a preparation for topical application.
According to a preferred embodiment of a method of preparing a tanning preparation according to the invention, a mixture is formed which comprises 10 wt% of N-acetyl-L-tyrosine, 20 wt% of butylene glycol,
2 wt% of phytantriol,
3 wt% of hydrolysed soya protein, 3 wt% of polysorbate-20,
1 wt% of riboflavin, remainder: water, and this mixture is taken up in an amount of 5%, in a water/ethanol/glycol mixture to form a lotion.
According to another embodiment, the present invention relates to a controlled release tanning preparation. With respect to the phenomenon of controlled release preparations the following explanation is given.
Stable emulsions, produced for application in food, pharmacy, personal care and cosmetics, lacquers and coatings, paper products, etc., are characterized by the presence of a nematic, liquid crystalline structure.
The rationale for the existence of thermodynamically stable liquid crystalline (LC) structures is dependant on the temperature, and it is a boundary condition for stable emulsions that these LC structures are manifest in the temperature range of storage and application of the particular product.
Griffin defined in the 50 's the famous HLB concept whereby it was stated that stable emulsions can be prepared when the HLB value was -10. Israelachvili et.al. (1975) showed that an optimum liquid crystalline phase exists in the case the emulsifier / emulsifier combination had an HLB value -10.
The nematic liquid crystalline structures reside in the continuous phase of emulsions. These are organised in double layers whereby the theme "like-dissolves-like" is applicable. The double layers, relative to the continuous phase applicable, may be organised as:
H == L «"* L == H (1)
L == H <r-\ H == L (2)
whereby « H » represents the hydrophilic (water-loving) part of the surface active agent, and « L » represents the lipophilic (oil-loving) part of the surface active agent. Thus, structure (1) will reside in the water phase and is characteristic for Oil-in-Water (O/W) emulsions. Structure (2) will reside in the oil phase and is therefore characteristic for Water-in-Oil (W/O) emulsions . The LC structure is present in the form of a sponge structure. A number of parameters are determining the characteristics of the frequently called "the fourth phase" . These are:
1. Mechanical strength of the LC phase. 2. Abundance of the LC phase .
3. The possibility of existence of the LC phase in the temperature range that is usually for personal care and cosmetic products (-10°C to +50°C) .
4. The possibility to make the liquid crystalline phase in a temperature range of -10 °C to +90 °C.
5. Oil droplet size distribution / particle size distribution of the dispersed phase.
Especially the mechanical strength of the LC is an important parameter for the cosmetic application of active ingredients relative to the bio-availability of these active ingredients. In traditional emulsion systems the LC structures are quickly deteriorated because of the influence of shear applied during rubbing in, the influence of electrolytes, the activity of enzymes present on the skin and because of the presence of liquid crystalline structures relative to the naturally occurring sebum (the sebum also exhibits liquid crystalline properties, and easily dissolves the LC structures present in cosmetic emulsions) .
Also, currently commercially available cosmetic emulsions are mostly stabilised by manipulation of the rheological properties by means of inappropriate use of rheological additives, ignoring the challenge and possibilities of the application of liquid crystalline behaviour.
As a consequence the behaviour of traditional emulsions applied for personal care and cosmetic products is such that the bio-availability of active ingredients is almost immediate.
Usually this is not very appreciated as the active period of the active principles is therefore short and the largest part of the active principles is processed "unused" .
Active principles could be considered to be moisturisers/humectants, oil/water-soluble UV-filters, flavonoids, saponines, alkaloids, terpenoids, vitamins, 2- hydroxy carboxylic acids (AHA's), insect repellents, amino acid biovectors, (poly) -saccharides, etc.
It is possible to increase the mechanical strength of the liquid crystalline structures on the skin during and after application, while maintaining the required sensorial properties of personal care and cosmetic emulsions. It has been found that this can be done using appropriate hydrocolloids such as naturals gums (such as xanthan gum, karaya gum, guar gum, gum ghatti, gum Arabic, etc.), cellulose derivatives (such as methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, etc.), synthetic hydrophilic products such as homo-and co-polymers of acrylic acid, methacrylic acid, crotonic acid, etc, natural clays such as hectorites, bentonites, montmorrilonites, and others.
The mechanical strength of the LC structures can easily be measured in terms of rheological parameters such as yield stress value, visco-elastic behaviour and flow patterns.
In this way it is possible to produce emulsions that do not show degradation on the time scale required for cosmetic application. While doing so the bio-availability of active ingredients is than turned to the other side of the spectrum and consequently the bio-availability is reduced to levels where the activity is at least insufficient and frequently not noticeable anymore .
Although Applicant does not wish to be bound by any theory, it is assumed that this can be obviated by the incorporation in the strengthened LC of structure molecules that are "recognised" by the skin, in particular the sebum and the first sub-cutaneous membranes composed of lecithin and similar phospholipids . Cholesterol is produced on the skin via bio-conversion of squalene and is incorporated in those lecithin membranes. It is connected to "siphon-molecules", identified as glycolipids and/or glycoproteins . To allow small molecules to pass the membrane the cholesterol molecule is temporarily pulled out of the lecithin double layer by means of a glycolipid or glycoprotein, under the influence of e.g. osmotic pressure. As soon as transport of the desired molecules (water, small carbohydrates, carbon dioxide, metal ions, etc.) has taken place the cholesterol molecule is put back in the lecithin membrane.
By building in cholesterol in the double layer composed of surface active agents the same mechanism can be used for a controlled release mechanism of active substances. Using the same receptors cholesterol can be pulled out of the double layer and make the contents of the liquid crystalline cavity available to the skin. This mechanism may coincide with enzymatic degradation of the liquid crystalline sponge structure. The naturally occuring receptors for cholesterol are thus used to enable controlled release.
A number of systems composed of surface active agents that for LC structures in either hydrophilic or lipophilic media were tested on this mechanism, to be identified as:
Glyceryl Stearate
I Potassium Stearate
Figure imgf000008_0001
Methylglucose Sesquistearate
Figure imgf000008_0002
PEG-20 Methylglucose Sesquistearate
Polyglyceryl-3 Methylglucose Distearate Glyceryl Stearate
Figure imgf000009_0001
PEG-100 Stearate
Cetearyl Polyglucoside Ceteareth-4
Ceteareth-10 Cetearyl Alcohol
Figure imgf000009_0002
Ceteareth-20
These systems (a) to (h) have an average HLB value of about
10.
The mechanical strength can be increased by using the before mentioned hydrocolloids. Cholesterol is soluble in the liquid crystalline phase made of a variety of amphiphilic molecules and therefore an artificial membrane is formed that has similar properties as the naturally occurring subcutaneous membranes, and that is treated accordingly. The emollients can be chosen from the emollients, which are used in personal care and cosmetic preparations, in a concentration in the range 0-45 %, preferably in the range 5- 20%. Examples of applicable emollients are triglycerides of long chain, predominantly unsaturated fatty acids such as vegetable oils and artificially made triglycerides of long chain unsaturated fatty acids, triglycerides of saturated medium chain fatty acids, liquid and semi-solid esters of mono- & polyhydric alcohols and carboxylic acids with 1-24 carbon atoms, liquid and semi-solid fatty alcohols & branched alcohols, their ethoxylates and propoxylates , liquid and semi-solid mineral and natural hydrocarbons, products having a steroid skeleton with an hydroxy functionality, their esters, ethoxylates and propoxylates, water-soluble products made by ethoxylation and/or propoxylation of suitable mono- and/or polyhydric alcohols and products usually identified as silicones such as cyclic and linear polydimethylsiloxanes and polyphenyltrimethylsiloxanes and derivates thereof made by ethoxylation and/or propoxylation.
The invention is explained in more detail with reference to the following examples and tanning tests carried out with different preparations. Example 1
An O/W lotion was prepared by mixing an oil phase and a water phase in a manner customary per se . The oil phase used consisted of: 0.50 kg of phenoxyethanol (Phenonip, trade name, product of Nipa Industries, UK) , 10.00 kg of an ester mixture, consisting of cetyl palmitate, octyl stearate and glyceryl stearate (Cetiol 868, product from Cognis) , 6.00 kg of emulsifier mixture of ceteareth-20 and ceteareth-12 (Emulgade SE, product from Cognis) , 2.00 kg of cetearyl alcohol (Lanette 0, product from Cognis) .
The water phase consisted of 76.50 kg of water and 5.00 kg of tanning mixture according to the invention, consisting of:
10 wt% of N-acetyltyrosine, 20 wt% of butylene glycol,
2 wt% of phytantriol,
3 wt% of hydrolysed vegetable protein, 3 wt% of polysorbate-20,
62 wt% of water.
Example 2
In a manner known per se, a gel-type preparation was prepared by mixing a premix consisting of:
0.80 kg of thickener (Carbopol Ultrez 10 Polymer, B.F. Goodrich), and 12.90 kg of water, with a mixture consisting of: 0.80 kg of triethanolamine (Merck & Co.), and
0.50 kg of phenoxyethanol (Phenonip, Nipa Industries), and mixing the mixture thus obtained with a water phase consisting of 80.00 kg of water and 5.00 kg of the tanning mixture according to the invention described in Example 1.
Example 3 (for comparison)
An 0/W lotion was formed in the same manner as in Example 1, and using the same substances and quantities, except that in the tanning mixture according to the invention the phytantriol used was replaced by adenosine triphosphate . A preparation of this type is disclosed by DE 37 32 154.
The preparations specified in the abovementioned examples were subjected to tests on human skin, using a tanning bed comprising 22 80-Watt lamps and a face tanner comprising 5 15-Watt lamps. The measuring equipment consisted of a melanin & erythema meter (Mexameter MX16 from Courage &_ Khazaka) .
The duration of an insolation was 20 minutes.
The following results were obtained:
Table 1
Figure imgf000011_0001
These results are shown in the accompanying figure 1 and can be summarized as follows:
Table 2
Figure imgf000011_0002
To summarize, it can be stated that after as little as 6 insolations using a product according to the invention, a significant difference of 20% can be seen compared with a known preparation. After as little as 4 insolations, incidentally, a difference of 12% is already visible, compared with the known preparation.
Example 4 :
Moisturisation using a controlled release preparation.
Emulsions were made, composed as described in table 3.
Table 3 : Moisturising emulsions
Figure imgf000012_0001
DMDM hydantoin = 1, 3-bis- (hydroxymethyl) -5 , 5-dimethylimidazolidine- 2,4-dione.
Isopropylisostearate is a spreading agent, which improves the spreadability of the preparation on the skin. Rheological additives are additives, which influence the mechanical strenght of the liquid crystalline structure of the emulsion to be prepared.
Procedure: Polyglyceryl-3 methylglucose distearate and cholesterol are dissolved at 85-90°C in about 25% water until a hazy, viscous gel is obtained. The formation of the liquid crystalline gel is monitored by optical microscopy. The rheological additives are dispersed at room temperature in the remainder of the water and this mixture is added to the liquid crystalline gel, and heated o 65°C. Finally the preservatives and glycerin are added and the mixture is kept at 65 °C. The oil phase is heated to 65°C and added slowly to the water phase.
After the addition the mixture is homogenised ©1500 rpm during 2 minutes, without stirring during the addition. The emulsion is stirred slowly with a planetary mixer while cooling gently. At
45-50°C the moisturiser is added
The results of emulsion 1 were compared to a similar emulsion in absence of Cholesterol, Xanthan Gum and Acrylates/Cio-3o Alkyl Acrylates Crosspolymer, whereby the formed emulsion is stable but where the mechanical strength is greatly reduced: emulsion 2.
The results were also compared to a similar emulsion in absence of Cholesterol, whereby an emulsion is formed that is stable, with unusually high mechanical strength of the LC structure: emulsion 3.
The efficacy of this controlled release emulsion system was tested by means of Trans Epidermal Water Loss (TEWL) measurements using TEWAMETER® by COURAGE &_ KHAZAKA.
The results of the TEWL measurements are depicted in fig.2, which clearly demonstrates that the activity of emulsion 3 is unacceptable relative low in moisturising ability because of insufficient bio-availability of the moisturiser.
Emulsion 2 has a much too high bio-availability of the moisturiser, while the system (emulsion 1) with build-in controlled release has a highly desirable bio-availability profile. Example 5
Tanning acceleration using a controlled release tanning preparation according to the invention.
In typical experiments emulsions were made, composed as described in Tables 4 and 5, by following the procedure indicated in Example 4.
Table 4: Tanning acceleration emulsions
Figure imgf000014_0001
Homosalate is added, as is well-known to improve the solubility of butyl methoxydibenzoylmethane. As butyl methoxydibenzoylmethane is a strong sequestering agent for transition metal ions the use of an additional sequestering agent such as trisodium ETDA is essential to avoid coloration of the final emulsion. As an alternative other UV filters can be used such as described in table 5 : the use of octocrylene instead of butyl methoxydibenzoylmethane & homosalate .
Table 5: Tanning acceleration emulsions
Figure imgf000015_0001
The results of the emulsions 4A/4B were compared to similar emulsions in absence of Cholesterol, Xanthan Gum and
Acrylates/Cio-3o Alkyl Acrylates Crosspolymer, whereby an emulsion is formed that is stable but where the mechanical strength is greatly reduced: emulsion 5A/5B.
The results were also compared to a similar emulsions in absence of Cholesterol, whereby emulsions were formed, which are stable, but with unusually high mechanical strength of the LC structure: emulsion 6A/6B.
The efficacy of this controlled release emulsion systems was tested by means of determination of melamin formation measurements using MEXAMETER® by COURAGE & KHAZAKA.
It was found, that melanin formation during exposition to UV-radiation was excellent for emulsion systems 4A/4B. Obviously the bio-availability of the system Acetyl Tyrosine / Phytantriol is high. The MEXAMETER reading for emulsion 4A was set at 100 % as a reference. It was observed that the MEXAMETER reading from emulsion 4B was 103 %.
For emulsion 5A/5B the MEXAMETER readings were respectively 92% and 94 %. Obviously the bio-availability for the emulsion systems 5A/5B is such that less functional material can be used for the production of melanin. The lower MEXAMETER readings for emulsions 5A/5B is attributed to the absence of a controlled release system using cholesterol. The reduced bio-availability of the active ingredients (Acetyl Tyrosine/Pythantriol) probably originates from a high trans-epidermal flux of the active ingredients disabling full utilisation thereof.
For emulsion 6A/6B the MEXAMETER readings were respectively
57% and 53 %. Obviously the bio-availability of these emulsion systems is too low. The reduced bio-availability in this case is attributed to the fact that the emulsion system is much too stable and that insufficient material can be released.
The activity of the system Acetyl Tyrosine / Phytantriol can thus be further improved using controlled release systems based on amphiphilic products that form a liquid crystalline (LC) phase in the emulsion. The mechanical strength of the LC phase can be monitored using a suitable rheological additive. Controlled release of active principles such as moisturisers or tanning accelerators can be monitored by incorporating cholesterol in the LC phase.

Claims

1. Tanning preparation for the skin comprising at least one tyrosine derivative of formula 1
COORi
J H C — NHR,
I
Figure imgf000017_0001
where
R1 = -H, -(CH2)X-CH3, x being an integer from 1 to 20, R2 = CH3CO-, CH3- (CH2)yCO-, y being an integer from 1 to 20, and an activator, characterized in that the activator consists of an aliphatic polyol having at least 10 C atoms in the molecule.
2. Tanning preparation according to claim 1, characterized in that the aliphatic polyol consists of a hexadecanetriol, in particular phytantriol.
3. Tanning preparation according to claim 1 or 2, characterized in that it comprises a tyrosine derivative of formula 1, where R1, R2, x and y have the abovementioned meanings and also comprises at least 0.01 wt% of phytantriol.
4. Tanning preparation according to one or more of claims 1 to 3 , characterized in that the preparation further comprises riboflavin.
5. Tanning preparation according to one or more of claims 1 to 4, characterized in that the preparation further comprises a UV filter.
6. Tanning preparation according to one or more of claims 1 to 5, characterized in that it is in the form of a gel, lotion, cream, foam, spray based on water and/or an aqueous alcohol and/or an aqueous glycol, or of an emulsion of the type O/W, W/0, O/W/O, etc.
7. Method of preparing a tanning preparation according to one or more of claims 1 to 6, characterized in that a mixture is formed which comprises
5 - 15 wt% of N-acetyl-L-tyrosine,
0.5 - 5 wt% of phytantriol,
15 - 25 wt% of butylene glycol,
1 - 5 wt% of hydrolysed vegetable protein, 0.1 - 5 wt% of polysorbate-20,
0 - 5 wt% of riboflavin, remainder: water/alcohol, and this mixture is taken up in an amount of from 1 to 10%, preferably 5%, in a pharmacologically acceptable base to form a preparation for topical application.
8. A controlled release tanning preparation for the skin comprising a stable emulsion containing a nematic liquid crystalline structure that is present in the continuous phase of the emulsion, based on self-assemblies of amphiphilic compounds, wherein said emulsion comprises a tanning preparation according to any of the claims 1 to 5, and wherein the mechanical strength of said liquid crystalline structure is increased by means of a suitable hydrocolloid and/or a spacing compound.
9. A controlled release tanning preparation according to claim 8, wherein said hydrocolloid is a natural gum and said spacing compound is selected from the group consisting of saturated long chain fatty alcohols and mono- and diglycerides of fatty acids .
10. A controlled release tanning preparation according to claim 8 or 9, wherein said structure further comprises cholesterol .
PCT/NL2001/000122 2000-02-15 2001-02-14 Tanning preparation for the skin WO2001060330A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DK01910238T DK1255531T3 (en) 2000-02-15 2001-02-14 Tanning preparation for skins
AT01910238T ATE268589T1 (en) 2000-02-15 2001-02-14 SKIN TANNING PRODUCTS
EP01910238A EP1255531B1 (en) 2000-02-15 2001-02-14 Tanning preparation for the skin
AU2001237816A AU2001237816A1 (en) 2000-02-15 2001-02-14 Tanning preparation for the skin
CA002400203A CA2400203A1 (en) 2000-02-15 2001-02-14 Tanning preparation for the skin
DE60103735T DE60103735T2 (en) 2000-02-15 2001-02-14 HAUTBRAÜNUNGSMITTEL
US10/218,037 US6649149B2 (en) 2000-02-15 2002-08-14 Tanning preparation for the skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1014389A NL1014389C2 (en) 2000-02-15 2000-02-15 Tanning preparation for the skin.
NL1014389 2000-02-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/218,037 Continuation US6649149B2 (en) 2000-02-15 2002-08-14 Tanning preparation for the skin

Publications (1)

Publication Number Publication Date
WO2001060330A1 true WO2001060330A1 (en) 2001-08-23

Family

ID=19770822

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2001/000122 WO2001060330A1 (en) 2000-02-15 2001-02-14 Tanning preparation for the skin

Country Status (12)

Country Link
US (1) US6649149B2 (en)
EP (2) EP1255531B1 (en)
AT (1) ATE268589T1 (en)
AU (1) AU2001237816A1 (en)
CA (1) CA2400203A1 (en)
DE (1) DE60103735T2 (en)
DK (1) DK1255531T3 (en)
ES (1) ES2222982T3 (en)
NL (1) NL1014389C2 (en)
PT (1) PT1255531E (en)
TR (1) TR200402262T4 (en)
WO (1) WO2001060330A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055029A2 (en) * 2001-01-16 2002-07-18 Roche Vitamins Ag Hair protection compositions
EP3124011A1 (en) * 2015-07-28 2017-02-01 Laboratoires M & L Concentrated cosmetic formulation base

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20120156144A1 (en) * 2002-10-25 2012-06-21 Foamix Foamable Compositions, Kits and Methods for Hyperhidrosis
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
BRPI0405956A (en) * 2004-12-29 2006-09-05 Natura Cosmeticos Sa cosmetic composition and process for preparing said cosmetic composition and cosmetic product
BRPI0503719A (en) 2005-09-09 2007-09-25 Natura Cosmeticos Sa cosmetic composition and process of preparing said composition
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
KR20090044269A (en) * 2007-10-31 2009-05-07 (주)아모레퍼시픽 Sustained-release nanoparticle and the cosmetic composition containing the same
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (en) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Topical tetracycline compositions.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011100358A2 (en) * 2010-02-09 2011-08-18 Fabrico Technology, Inc. Systems and methods for detecting target analytes
US9301521B2 (en) * 2013-03-13 2016-04-05 The United States Of America, As Represented By The Secretary Of Agriculture Bee attractants
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
KR102598477B1 (en) 2016-09-21 2023-11-06 (주)아모레퍼시픽 Oil-in-water cosmetic composition
EP3498256A1 (en) * 2017-12-12 2019-06-19 Spray Company SRL Cosmetic formulation for the removal of skin stains
DE102018107718A1 (en) * 2018-03-29 2019-10-02 Ultrasun Ag A process for the preparation of a starting formulation for a dermatological sunscreen composition and for the preparation of a dermatological sunscreen composition

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836849A1 (en) * 1987-12-09 1989-06-22 Induchem Ag PRAEPARAT, COSMETIC SUN PROTECTION AGAIN, AND METHOD OF INTRODUCING AN ACTIVE INGREDIENT IN THE SKIN
US5372805A (en) * 1992-07-16 1994-12-13 Bayer Aktiengesellschaft Cosmetic sunscreen
GB2304573A (en) * 1995-08-31 1997-03-26 Fernsoft Skin care composition comprising sunscreen, humectant and exfolliant
US5756108A (en) * 1994-11-10 1998-05-26 L'oreal Oily phase in an aqueous phase dispersion stabilized by cubic gel particles and method of making
US5834013A (en) * 1994-06-08 1998-11-10 L'oreal Cosmetic or dermatological composition in the form of an aqueous and stable dispersion of cubic gel particles based on phytanetriol and containing a surface-active agent which has a fatty chain, as dispersing and stabilizing agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69103487T2 (en) * 1990-07-11 1995-02-16 Quest Int Perfumed structured emulsions in personal care products.
GB9420535D0 (en) * 1994-10-12 1994-11-30 Procter & Gamble Cosmetic make-up compositions
US5656280A (en) * 1994-12-06 1997-08-12 Helene Curtis, Inc. Water-in-oil-in-water compositions
US5744062A (en) * 1996-08-29 1998-04-28 R.I.T.A. Corporation Balanced emulsifier blends for oil-in-water emulsions
DE19645319A1 (en) * 1996-11-04 1998-05-07 Beiersdorf Ag Foaming composition, useful as skin care medium e.g. as shaving foam
SK283697B6 (en) * 1999-03-03 2003-12-02 Slovakofarma, A. S. Dermatological compositions containing a liquid crystal vehicle and method of preparing same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836849A1 (en) * 1987-12-09 1989-06-22 Induchem Ag PRAEPARAT, COSMETIC SUN PROTECTION AGAIN, AND METHOD OF INTRODUCING AN ACTIVE INGREDIENT IN THE SKIN
US5372805A (en) * 1992-07-16 1994-12-13 Bayer Aktiengesellschaft Cosmetic sunscreen
US5834013A (en) * 1994-06-08 1998-11-10 L'oreal Cosmetic or dermatological composition in the form of an aqueous and stable dispersion of cubic gel particles based on phytanetriol and containing a surface-active agent which has a fatty chain, as dispersing and stabilizing agent
US5756108A (en) * 1994-11-10 1998-05-26 L'oreal Oily phase in an aqueous phase dispersion stabilized by cubic gel particles and method of making
GB2304573A (en) * 1995-08-31 1997-03-26 Fernsoft Skin care composition comprising sunscreen, humectant and exfolliant

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055029A2 (en) * 2001-01-16 2002-07-18 Roche Vitamins Ag Hair protection compositions
WO2002055029A3 (en) * 2001-01-16 2002-12-12 Roche Vitamins Ag Hair protection compositions
EP3124011A1 (en) * 2015-07-28 2017-02-01 Laboratoires M & L Concentrated cosmetic formulation base
FR3039396A1 (en) * 2015-07-28 2017-02-03 Laboratoires M&L BASE OF CONCENTRATED COSMETIC FORMULATION

Also Published As

Publication number Publication date
US20030118527A1 (en) 2003-06-26
AU2001237816A1 (en) 2001-08-27
DE60103735T2 (en) 2005-06-23
DE60103735D1 (en) 2004-07-15
DK1255531T3 (en) 2004-10-18
PT1255531E (en) 2004-10-29
EP1255531B1 (en) 2004-06-09
TR200402262T4 (en) 2004-12-21
CA2400203A1 (en) 2001-08-23
US6649149B2 (en) 2003-11-18
EP1255531A1 (en) 2002-11-13
EP1468668A2 (en) 2004-10-20
NL1014389C2 (en) 2001-08-16
EP1468668A3 (en) 2005-02-02
ATE268589T1 (en) 2004-06-15
ES2222982T3 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
EP1255531B1 (en) Tanning preparation for the skin
EP0934053B1 (en) Cosmetic or dermatological microemulsions
JP3687277B2 (en) Whitening cosmetics
JP3595206B2 (en) Cosmetic and / or dermatological compositions containing salicylic acid or salicylic acid derivatives and uses thereof
EP1513492B1 (en) Microemulsions having a binary phase differentiability and active substance differentiability, the production thereof and their use, particularly for the topical supply of oxygen
JP3162342B2 (en) Use of arbutin monoester as depigmenting agent
EP0754449A1 (en) Skin whitening composition and/or anti-aging composition and uses thereof
EP0646368B1 (en) A gel-resembling composition containing organopolysiloxane, without a gelling agent used in cosmetic and dermatology
US9827194B2 (en) Surfactant-free oil-in-water type emulsion, process for preparation thereof and its uses
US20090130036A1 (en) Self tanning product having slimming, firming and toning properties associated therewith
MX2012013506A (en) Polymer combinations for cosmetic preparations.
EP1282393B1 (en) External application for enhancing the skin permeability of the active components therein
EP2100586A1 (en) Cosmetic composition comprising an ascorbic acid or salicylic acid compound
JP2002138014A (en) Fine emulsion composition
CA2181738A1 (en) Cosmetic or dermatological filtering composition
EP0679388B1 (en) Cosmetic and/or dermatologic skin depigmentation composition and its use
DE10057767A1 (en) Deodorant and antiperspirant composition comprises dispersed liquid crystals forming a cubic phase
US20010053350A1 (en) Cosmetic composition comprising N-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives
JP3643690B2 (en) Skin preparation
JP3382146B2 (en) External preparation for skin
JP2001240511A (en) Composition comprising n-cholesteryloxycarbonyl-4- paraaminophenol and one of hydroquinone or its derivative as base
JP2000198724A (en) Skin-beautifying preparation for external use for skin
JP3400313B2 (en) Percutaneous absorption promoting skin external preparation
MXPA99007373A (en) Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use
JP2004026698A (en) Humectant and skin care preparation for external use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001910238

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2400203

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10218037

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001910238

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001910238

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP